Clinics I work with
Selected research
-
CC-90009, a novel cereblon E3 ligase modulator targets acute myeloid leukemia blasts and leukemia stem cells.
Blood
-
Phase I, multicenter, dose-escalation study of avadomide in adult Japanese patients with advanced malignancies.
Cancer science
-
Avadomide plus obinutuzumab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (CC-122-NHL-001): a multicentre, dose escalation and expansion phase 1 study.
The Lancet. Haematology
Contact me
- Request appointment
- Refer a patient
- (415) 353-2421